期刊文献+

Wnt信号通路成员APC抑癌基因在肾上腺皮质腺瘤中杂合性缺失的研究

Loss of Heterozygosity of the Member of Wnt Signaling Pathways:APC Tumor Suppressor Gene in Adrenocortical Adenoma
原文传递
导出
摘要 目的:探讨APC基因杂合性缺失在肾上腺皮质腺瘤中的意义。方法:采用聚合酶链反应-限制性酶切片段长度多态性(PCR-RFLP)方法研究Wnt信号通路成员APC基因11外显子Rsal酶切位点和15外显子MspI酶切位点多态性,分析42例肾上腺皮质腺瘤中APC基因杂合性缺失。结果:在42例肾上腺皮质腺瘤组中杂合子有30例(71.4%),未发现杂合性缺失。结论:肾上腺皮质腺瘤未发现APC基因杂合性缺失现象,据此认为APC基因杂合性缺失在肾上腺皮质腺瘤发生发展过程中可能无明显关联。 Objectlve:To investigate the significance of the loss of heterozygosity (LOH) of adenomatous polyposis coli (APC) gene in adrenocortical adenoma. Methods. The polymorphism of Rsa I sites in the exonll and Msp I sites in the exonl5 of APC gene, the member of Wnt signaling pathways were studied by by using Polymer- ase Chain Reaction/ Restriction Fragment Length Polymorphism(PCR-RLFP), LOH of adenomatous polyposis coil (APC) were analyzed in 42 adrenocortical adenomas. Results: In 42 adrenocortical adenoma samples, 30 were informative(30/42, 71.4%), but none of them show LOH. Conclusions: None of the APC gene adrenocortical adenomas show LOH, it is supposed that the LOH of APC gene might not correlated with the development of adrenocortical adenomas.
出处 《临床泌尿外科杂志》 北大核心 2010年第3期222-225,共4页 Journal of Clinical Urology
关键词 肾上腺皮质腺瘤 WNT信号通路 APC基因 杂合性缺失 adrenocortical adenomas Wnt signaling pathway APC loss of heterozygosity
  • 相关文献

参考文献20

  • 1Karim R,Tse G,Putti T,et al.The significance of the Wnt pathway in the pathology of human cancers[J].Pathology,2004,36(2):120-128.
  • 2Pecina-Slaus N,Pavelic K,Pavelic J.Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas[J].Mol Med,1999,77 (5):446-453.
  • 3Collu G M,Brennan K.Cooperation between Wnt and Notch signalling in human breast cancer[J].Breast Cancer Res,2007,9(3):105.
  • 4Clements W M,Wang J,Sarnaik A,et al.Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer[J].Cancer Res,2002,62:3503-3506.
  • 5Kolligs F T,Bommer G,G6ke B.Wnt/beta-catenin/tcf signaling:Acritical pathway in gastrointestinal tumorigenesis[J].Digestion,2002,66:131-144.
  • 6Clements W M,Lowy A M,Groden J.Adenomatous polyposis coli/betacatenininteraction and downstream targets:Altered gene expression in gastrointestinal tumors[J].Clin Colorectal Cancer,2003,3:113-120.
  • 7Rezk S,Brynes R K,Nelson V,et al.Beta-Catenin expression in thyroid follicular lesions:potential role in nuclear envelope changes in papillary carcinomas[J].Endocr Pathol,2004,15:329-337.
  • 8Kim W,Peter W,Sarah M,et al.β-catenin mutation and expression analysis in ovarian cancer:exion 3 mutations and nuclear translocation in 16% of endometrioid tumours[J].Cancer,1999,82:625-629.
  • 9Shuho Semba,Shuang-Yin Han,Hidetoshi Ikeda,et al.Frequent nuclear accumulation of β-catenin in pituitary adenoma[J].American Cancer Society,2001,91:42-47.
  • 10Peyman B,Daniel L,G(o)ran A,et al.Stabizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of swedish patients[J].Molecular Cancer,2008,7:53.

二级参考文献13

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部